Home › Core › ISCC-IDs › 28CrY15pg2DC9

View ISCC-ID

Core Data

28CrY15pg2DC9
ISCC-ID - digital asset identifier
CCN5eBixf71nU-CTXvLLMqLH9gB-CDAfiYDhNDFnV-CR8BJaE8aszwe
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

the continuous intravenous administration of physiological salt solution

Ledger Reference

coblo
Source Ledger/Blockchain
75779
N-th ISCC Decleration on source ledger
25208c798e37872bb5b19744d562f1f6b74102da024ca8fa65993a51875216ea
Hash of block that includes the ISCC-DECLARATION
ce61cdee7b724194a46d374d9bc58987985718934b26afbc15a1b21fc1b39e41
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "THE CONTINUOUS INTRAVENOUS ADMINISTRATION OF PHYSIOLOGICAL SALT SOLUTION", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "W. EDWARD GALLIE", "@type": "Person"}, {"name": "R. I. HARRIS", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1398077/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Ovid Technologies (Wolters Kluwer Health)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1097/00000658-193003000-00010", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCN5eBixf71nU-CTXvLLMqLH9gB-CDAfiYDhNDFnV-CR8BJaE8aszwe", "propertyID": "ISCC"}], "datePublished": "1930-03-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close